ArticleOncoTargets and therapy2019

Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.